Quidel has received the CE mark of conformity for the Savanna multiplex molecular analyzer and its respiratory virus panel, RVP4. The Savanna platform allows the identification of up to 12 pathogens, or targets, with a single assay in less than 30 minutes. The RVP4 panel is a rapid multiplex nucleic acid test for the simultaneous detection and differentiation of influenza A, influenza B, respiratory syncytial virus and coronavirus. CE marking allows Quidel to sell the Savanna system in Europe as well as in other countries where this standard has been adopted.